Ask Warren

Korea Arlico Pharm

260660 · KOSDAQ · ₩260660 · 알리코제약

₩1,950▼ ₩40 (2.01%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

20252024202320222021
Revenue₩201B₩190B₩187B₩168B₩140B
Cost of sales₩97B₩91B₩77B₩61B₩53B
Gross profit₩104B₩100B₩110B₩107B₩88B
Operating income₩989M−₩5.2B₩3.1B₩9.9B₩4.8B
Net income−₩605M−₩5.4B₩3.1B₩8B₩4.9B
Net income to shareholders−₩605M−₩5.4B₩3.1B₩8B₩4.9B

Balance sheet

20252024202320222021
Total assets₩172B₩172B₩173B₩154B₩121B
Current assets₩83B₩85B₩84B₩82B₩69B
Cash and equivalents₩19B₩15B₩19B₩23B₩9.5B
Total liabilities₩94B₩93B₩84B₩65B₩40B
Current liabilities₩74B₩75B₩70B₩57B₩34B
Borrowings₩16B₩16B₩46B₩31B₩12B
Total equity₩78B₩80B₩89B₩89B₩81B
Shareholders' equity₩78B₩80B₩89B₩89B₩81B

Cash flow

20252024202320222021
Cash from operations₩10B−₩8.6B₩7.1B₩4.8B₩9B
Capital spending₩3.1B₩3.5B₩23B₩18B₩5.3B
Free cash flow₩6.9B−₩12B−₩16B−₩13B₩3.7B
Dividends paid₩352M₩302M₩179M₩151M₩958M

Consolidated where available. Amounts in won.

Also known as: Korea Arlico Pharm / 알리코제약 / 260660 / KRX:260660

Source: KRX statistical information